DETECT Nitazenes Act of 2026
- Bill Number
- H.R. 8022
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Science, Technology, Communications
- Status
- Introduced
- Latest Action
- 2026-03-20: Referred to the Subcommittee on Emergency Management and Technology.
- Last Updated
- 2026-05-16T08:07:27Z
AI-Generated Summary
Purpose
The DETECT Nitazenes Act of 2026 (H.R. 8022) aims to improve the U.S. government's ability to detect, identify, and disrupt highly potent synthetic opioids known as nitazenes (a class of drugs similar to fentanyl but effective in extremely small amounts). It requires collaboration between the Department of Homeland Security's (DHS) Science and Technology Directorate and the Drug Enforcement Administration (DEA).
Key Provisions
- Amends Section 302(15) of the Homeland Security Act of 2002 (6 U.S.C. 182(15)) to expand the Directorate's responsibilities.
- Mandates development of technologies to detect and counter illicit substances, explicitly including nitazenes.
Significant Changes to Existing Law
- Updates the list of targeted substances from "fentanyl and xylazine" (a veterinary sedative often mixed with opioids) to "fentanyl, xylazine, and nitazenes".
- This is a targeted textual amendment to an existing provision outlining DHS research and development duties.
Potential Impacts
- Government agencies: Enhances DHS's technical capabilities for border security and drug interdiction; fosters DEA-DHS coordination.
- Citizens: Could reduce overdose deaths by improving detection of nitazenes at ports of entry, addressing a growing public health threat.
- International relations: May indirectly pressure drug-producing countries by strengthening U.S. enforcement tools.
Main Stakeholders Affected
- DHS Science and Technology Directorate: Primary entity responsible for new detection tech.
- DEA: Partner in development efforts.
- Law enforcement and border officials: Benefit from improved tools.
- Public health agencies and communities: Impacted by reduced influx of deadly drugs.
Notable Legal, Constitutional, or Political Implications
- Legal: Straightforward statutory update; no new funding or authorities created, relying on existing DHS mandates.
- Constitutional: No apparent issues; aligns with federal powers over interstate commerce and national security.
- Political: Responds to the evolving opioid crisis by targeting emerging synthetic drugs, potentially bipartisan appeal given introducers from both parties.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Pfluger, August [R-TX-11]
Cosponsors (2)
Rep. Vindman, Eugene Simon [D-VA-7], Rep. Baumgartner, Michael [R-WA-5]
Recent Actions
- 2026-03-20: Referred to the Subcommittee on Emergency Management and Technology.
- 2026-03-19: Referred to the House Committee on Homeland Security.
- 2026-03-19: Introduced in House
- 2026-03-19: Introduced in House
Bill Versions
- Detection Equipment and Technology Evaluation to Counter the Threat of Nitazenes Act of 2026 — issued 2026-03-19 — PDF (2 pages)